Trial Profile
A multi-center, randomized, controlled trial with programmed introduction of Sirolimus-based, Calcineurin inhibitor free immunosuppression in recipients of non-heart-beating donor kidney grafts.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 08 Oct 2013
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary) ; Tacrolimus
- Indications Renal transplant rejection
- Focus Adverse reactions; Therapeutic Use
- Acronyms PRINS
- 24 Aug 2011 New trial record